SERPINE1 and hepatocellular carcinoma: In conclusion, CAF-derived miR-642a-3p promotes hepatocellular carcinoma cell migration, invasion, and EMT by targeting SERPINE1 (Fig. 6), suggesting its potential as a molecular marker for HCC treatment.